NangioTx is a pharmaceutical company developing peptide-drug formulations for blood-vessel regeneration. Blood-vessel formation induced by our patent-pending V-10 peptide restores blood flow, promotes tissue regeneration and saves limbs in models of peripheral artery disease.
| Website | http://nangiotx.com |
| Revenue | $7 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2015 |
| Address | 1180 Raymond Blvd, Newark, New Jersey 07102, US |
| Phone | +1 646-883-1386 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
| Keywords | Tissue Regeneration, Pharmaceutical, Limb Salvage, Therapeutic Peptides, Regenerative Medicine, Drug Delivery, Biotechnology, Peptide Therapeutics, Vascular Disease, Wound Healing, Pharmaceutical Development, Clinical Trials, Drug Discovery, Biopharma, Perfusion |
| Competitors | AngioDynamics, BIOTRONIK, Boston Scientific, Medtronic, Terumo, Penumbra, Inc., Stryker, Philips, Edwards Lifesciences, Abbott +39 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular NangioTx employee's phone or email?
The NangioTx annual revenue was $7 million in 2026.
NangioTx is based in Newark, New Jersey.
The NAICS codes for NangioTx are [54171, 541, 54, 541714, 5417].
The SIC codes for NangioTx are [87, 873].